Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Heier

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Harvard Health Letter|March 31, 2016
Ask the doctor. I have wet macular degeneration. I am trying to decide between Avastin and Lucentis. Which drug is better?Jeffrey S Heier
Harvard Health Letter|June 24, 2011
Ask the doctor. I think I may have cataracts. I heard somewhere that they need to be ripe before I get surgery. Is that true?Jeffrey S Heier
Retina (Philadelphia, Pa.)|June 26, 2009
Pathology beyond neovascularization: new targets in age-related macular degenerationJeffrey S Heier
Retina (Philadelphia, Pa.)|May 21, 2020
Futility as the Basis for Suspending Treatment of Neovascular Age-Related Macular Degeneration: An Important but not Easily Defined ConceptJeffrey S Heier
Ophthalmology|May 31, 2021
ReplyJeffrey S Heier
Ophthalmology|May 7, 2013
Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatmentsJeffrey S Heier
Harvard Health Letter|June 30, 2010
By the way, doctor. My 78-year-old husband has wet macular degeneration. He is being treated with a drug called Avastin. Is that a good choice?Jeffrey S Heier
Developments in Ophthalmology|October 27, 2015
Choroidal Neovascularization Secondary to Myopia, Infection and InflammationMarissa L Weber, Jeffrey S Heier
JAMA Ophthalmology|May 27, 2016
Chronically Retained Intraocular AirShilpa J Desai, Jeffrey S Heier
Ophthalmic Surgery, Lasers & Imaging Retina|February 22, 2020
Long-Term Follow-Up of Efficacy and Safety of YAG Vitreolysis for Symptomatic Weiss Ring FloatersChirag P Shah, Jeffrey S Heier
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Harvard Health Letter|March 31, 2016
Ask the doctor. I have wet macular degeneration. I am trying to decide between Avastin and Lucentis. Which drug is better?Jeffrey S Heier
Harvard Health Letter|June 24, 2011
Ask the doctor. I think I may have cataracts. I heard somewhere that they need to be ripe before I get surgery. Is that true?Jeffrey S Heier
Retina (Philadelphia, Pa.)|June 26, 2009
Pathology beyond neovascularization: new targets in age-related macular degenerationJeffrey S Heier
Retina (Philadelphia, Pa.)|May 21, 2020
Futility as the Basis for Suspending Treatment of Neovascular Age-Related Macular Degeneration: An Important but not Easily Defined ConceptJeffrey S Heier
Ophthalmology|May 31, 2021
ReplyJeffrey S Heier
Ophthalmology|May 7, 2013
Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatmentsJeffrey S Heier
Harvard Health Letter|June 30, 2010
By the way, doctor. My 78-year-old husband has wet macular degeneration. He is being treated with a drug called Avastin. Is that a good choice?Jeffrey S Heier
Developments in Ophthalmology|October 27, 2015
Choroidal Neovascularization Secondary to Myopia, Infection and InflammationMarissa L Weber, Jeffrey S Heier
JAMA Ophthalmology|May 27, 2016
Chronically Retained Intraocular AirShilpa J Desai, Jeffrey S Heier
Ophthalmic Surgery, Lasers & Imaging Retina|February 22, 2020
Long-Term Follow-Up of Efficacy and Safety of YAG Vitreolysis for Symptomatic Weiss Ring FloatersChirag P Shah, Jeffrey S Heier
Pageof 16